tiprankstipranks
KOREA UNITED PHARM, INC. (KR:033270)
:033270
South Korea Market
033270
KOREA UNITED PHARM, INC.
RESEARCH TOOLSreports

KOREA UNITED PHARM, INC. (033270) Ratios

― Followers

KOREA UNITED PHARM, INC. Ratios

KR:033270's free cash flow for Q2 2026 was ₩0.60. For the 2026 fiscal year, KR:033270's free cash flow was decreased by ₩ and operating cash flow was ₩0.18. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 5.52 5.63 5.08 3.37 3.41
Quick Ratio
 4.30 4.28 3.79 2.69 2.78
Cash Ratio
 0.77 0.84 0.70 0.33 0.41
Solvency Ratio
 1.20 0.77 0.65 0.65 0.67
Operating Cash Flow Ratio
 1.54 1.07 0.56 0.70 0.97
Short-Term Operating Cash Flow Coverage
 25.42 25.46 15.31 1.78 2.90
Net Current Asset Value
₩ 226.94B₩ 203.85B₩ 177.03B₩ 154.56B₩ 144.36B
Leverage Ratios
Debt-to-Assets Ratio
 0.03 0.03 0.03 0.09 0.07
Debt-to-Equity Ratio
 0.03 0.03 0.04 0.11 0.09
Debt-to-Capital Ratio
 0.03 0.03 0.04 0.10 0.08
Long-Term Debt-to-Capital Ratio
 0.02 0.02 0.03 0.03 0.02
Financial Leverage Ratio
 1.15 1.14 1.17 1.24 1.24
Debt Service Coverage Ratio
 14.91 22.44 19.78 1.96 2.35
Interest Coverage Ratio
 315.03 281.78 116.19 33.94 59.12
Debt to Market Cap
 0.05 0.04 0.05 0.10 0.09
Interest Debt Per Share
 943.74 869.24 1.10K 2.87K 2.10K
Net Debt to EBITDA
 -0.41 -0.43 -0.31 0.23 0.06
Profitability Margins
Gross Profit Margin
59.02%60.74%56.79%56.99%55.34%
EBIT Margin
17.99%16.94%16.13%21.76%20.21%
EBITDA Margin
21.82%20.94%20.04%25.37%23.53%
Operating Profit Margin
16.52%16.94%19.49%19.70%18.37%
Pretax Profit Margin
30.07%17.25%15.96%21.54%20.35%
Net Profit Margin
25.55%13.27%11.24%17.30%17.25%
Continuous Operations Profit Margin
25.55%13.27%11.24%17.30%17.25%
Net Income Per EBT
84.96%76.89%70.41%80.32%84.75%
EBT Per EBIT
182.07%101.86%81.89%109.34%110.81%
Return on Assets (ROA)
13.34%7.37%6.85%10.29%10.83%
Return on Equity (ROE)
16.62%8.43%7.99%12.74%13.40%
Return on Capital Employed (ROCE)
9.53%10.37%13.22%13.87%13.70%
Return on Invested Capital (ROIC)
8.05%7.94%9.27%10.39%10.92%
Return on Tangible Assets
13.60%7.53%6.98%10.50%11.07%
Earnings Yield
26.33%12.30%12.13%11.97%13.44%
Efficiency Ratios
Receivables Turnover
 5.51 6.20 5.81 0.00 6.48
Payables Turnover
 9.41 12.93 19.20 14.82 14.03
Inventory Turnover
 1.84 1.76 2.01 2.44 2.85
Fixed Asset Turnover
 1.55 1.69 1.82 1.80 1.92
Asset Turnover
 0.52 0.56 0.61 0.59 0.63
Working Capital Turnover Ratio
 1.32 1.38 1.57 1.69 1.74
Cash Conversion Cycle
 226.19 237.57 225.32 124.89 158.20
Days of Sales Outstanding
 66.21 58.90 62.86 0.00 56.36
Days of Inventory Outstanding
 198.75 206.90 181.48 149.52 127.86
Days of Payables Outstanding
 38.77 28.23 19.01 24.63 26.01
Operating Cycle
 264.96 265.80 244.33 149.52 184.22
Cash Flow Ratios
Operating Cash Flow Per Share
 5.27K 3.13K 1.82K 3.46K 4.31K
Free Cash Flow Per Share
 2.60K 1.70K 379.25 1.32K 2.67K
CapEx Per Share
 2.68K 1.44K 1.44K 2.14K 1.63K
Free Cash Flow to Operating Cash Flow
 0.49 0.54 0.21 0.38 0.62
Dividend Paid and CapEx Coverage Ratio
 1.61 1.70 0.98 1.36 2.15
Capital Expenditure Coverage Ratio
 1.97 2.18 1.26 1.62 2.63
Operating Cash Flow Coverage Ratio
 5.65 3.65 1.71 1.26 2.11
Operating Cash Flow to Sales Ratio
 0.28 0.18 0.09 0.18 0.24
Free Cash Flow Yield
15.74%8.89%2.08%4.80%11.75%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 3.70 7.29 8.25 8.35 7.44
Price-to-Sales (P/S) Ratio
 0.88 1.08 0.93 1.45 1.28
Price-to-Book (P/B) Ratio
 0.58 0.69 0.66 1.06 1.00
Price-to-Free Cash Flow (P/FCF) Ratio
 6.36 11.25 48.02 20.85 8.51
Price-to-Operating Cash Flow Ratio
 3.45 6.09 9.99 7.96 5.28
Price-to-Earnings Growth (PEG) Ratio
 0.03 0.39 -0.25 1.06 0.13
Price-to-Fair Value
 0.58 0.69 0.66 1.06 1.00
Enterprise Value Multiple
 3.63 4.72 4.31 5.93 5.51
Enterprise Value
 235.75B 285.22B 249.49B 419.59B 340.25B
EV to EBITDA
 3.62 4.72 4.31 5.93 5.51
EV to Sales
 0.79 0.99 0.86 1.50 1.30
EV to Free Cash Flow
 5.70 10.30 44.78 21.70 8.60
EV to Operating Cash Flow
 2.81 5.58 9.31 8.28 5.33
Tangible Book Value Per Share
 30.59K 27.19K 27.02K 25.24K 22.22K
Shareholders’ Equity Per Share
 31.24K 27.83K 27.65K 25.88K 22.82K
Tax and Other Ratios
Effective Tax Rate
 0.15 0.23 0.30 0.20 0.15
Revenue Per Share
 18.73K 17.68K 19.65K 19.06K 17.73K
Net Income Per Share
 4.79K 2.35K 2.21K 3.30K 3.06K
Tax Burden
 0.85 0.77 0.70 0.80 0.85
Interest Burden
 1.67 1.02 0.99 0.99 1.01
Research & Development to Revenue
 0.05 0.12 0.06 0.12 0.06
SG&A to Revenue
 0.14 0.14 0.13 0.13 0.13
Stock-Based Compensation to Revenue
 <0.01 <0.01 <0.01 <0.01 <0.01
Income Quality
 1.10 1.33 0.83 1.05 1.41
Currency in KRW